Terapio - the Esperanto word for therapy - is developing a pipeline of therapies based on the normally-occurring transport protein RLIP76 that moves free-radical toxins out of cells before significant damage can occur. The RLIP76 protein primarily works though the oxidative stress pathway and provides benefit as both a prophylactic and post exposure treatment. Although naturally present in cells, increasing the amount of this protein available to normal cells affords them an even greater ability to deal with toxins from a variety of sources, including chemicals and radiation. Initial applications include developing the RLIP76 protein as a medical countermeasure for radiation exposure and chemical threats to civilian, military, and first responder populations. The RLIP76 protein primarily works though the oxidative stress pathway and provides benefit as both a prophylactic and post exposure treatment.
